All In Biotech

Drug Trial Radar · NCT07214571

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus Who Are at High Risk of Progression to Severe Disease

Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 192 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

192

Planned (sponsor's estimate)

Start

Dec 11, 2025

Primary completion

Dec 30, 2026

Study completion Dec 30, 2026

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.

Conditions

  • Respiratory Syncytial Virus Infections

Interventions

  • S-337395Drug

    S-337395 will be administered per schedule specified in the arm description.

  • PlaceboDrug

    Placebo matched to S-337395 will be administered per schedule specified in the arm description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in RSV Ribonucleic Acid (RNA) Load by Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) (Nasopharyngeal Swab) at Day 2Time frame: Baseline, Day 2
  2. Change From Baseline in RSV RNA Load by qRT-PCR (Nasopharyngeal Swab) at Day 4Time frame: Baseline, Day 4
  3. Change From Baseline in RSV RNA Load by qRT-PCR (Nasopharyngeal Swab) at Day 6Time frame: Baseline, Day 6

Locations

89 sites in 8 countries. Site status is shown where the registry gives one.

  • LA Universal Research Center, Inc.

    Los Angeles, California · Recruiting

  • Central Valley Research

    Modesto, California · Recruiting

  • Med Partnes, Inc - Elligo- PPDS

    Toluca Lake, California · Recruiting

  • Hope Clinical Trials - 3970 W Flagler St.

    Coral Gables, Florida · Recruiting

  • Beautiful Minds Clinical Research Center

    Cutler Bay, Florida · Recruiting

  • Doral Medical Research

    Hialeah, Florida · Recruiting

  • Southern Clinical Research

    Miami, Florida · Recruiting

  • LCC Medical Research - Miami - BTC - PPDS

    Miami, Florida · Recruiting

  • Global Health Clinical Trials

    Miami, Florida · Recruiting

  • Nuren Medical and Research Center

    Miami, Florida · Recruiting

  • Continental Clinical Research, LLC

    Miami, Florida · Recruiting

  • Dynamic Medical Research, LLC - Miami

    Miami, Florida · Withdrawn

  • Miami Clinical Research, LLP.

    Miami, Florida · Recruiting

  • Reed Medical Research

    Miami, Florida · Recruiting

  • Palm Springs Community Health Center

    Miami Lakes, Florida · Recruiting

  • Oceanic Research Group, LLC

    North Miami Beach, Florida · Recruiting

  • CDC Research Institute, LLC

    Port Saint Lucie, Florida · Recruiting

  • Cordova Research Insittute

    Sweetwater, Florida · Recruiting

  • Better Life Clinical Research LLC

    Tampa, Florida · Recruiting

  • Research Bay,Inc.

    Tampa, Florida · Recruiting

  • Santos Research Center - 5927 Webb Rd

    Tampa, Florida · Recruiting

  • Angels Clinical Research Institute Tampa-Palm Springs

    Tampa, Florida · Recruiting

  • Covenant Pulmonary Criticial Care and Research Ins

    East Point, Georgia · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • University of Massachusetts

    Worcester, Massachusetts · Recruiting

  • Clay Platte Family Medicine - CCT Research

    Kansas City, Missouri · Recruiting

  • NYC Health + Hospitals/Lincoln Medical Center - BRANY - PPDS

    The Bronx, New York · Recruiting

  • Prime Global Research, Inc.

    The Bronx, New York · Recruiting

  • Progressive Medicine of the Triad, LLC

    Winston-Salem, North Carolina · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • Epic Medical Research - Chickasha

    Chickasha, Oklahoma · Recruiting

  • Rhode Island Hospital

    Providence, Rhode Island · Recruiting

  • Epic Med. Research LLC, DeSoto

    DeSoto, Texas · Recruiting

  • DCT-McAllen Primary Care Research, LLC

    McAllen, Texas · Recruiting

  • SMS Clinical Research, LLC - 400 W. Kearney St

    Mesquite, Texas · Recruiting

  • Clinical Research Partners LLC

    Richmond, Virginia · Recruiting

  • Frontier Clinical Research Waterfront

    Morgantown, West Virginia · Recruiting

  • Fundación Huésped - PPDS

    CABA, Buenos Aires, Argentina · Recruiting

  • AES - AS - Glenny Corp. S.A. Buenos Aires

    CABA, Buenos Aires, Argentina · Recruiting

  • CEMLO - Centro de Especialidades Médicas

    Lobos, Buenos Aires, Argentina · Recruiting

Showing 40 of 89 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.